LENVIMA® for locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer

LENVIMA resources for RAI-R differentiated thyroid cancer

RAI-R=radioactive iodine-refractory; DTC=differentiated thyroid cancer; AR=adverse reaction.

For questions about LENVIMA, email Eisai Medical Information at esi_oncmedinfo@eisai.com or call 1-888-274-23781-888-274-2378.

Eisai Engage logo

Eisai Engage

Connect to HCP services at Eisai Engage to request materials for your practice, contact a sales representative, and more.

Visit Eisai Engage now